DOCSLIB.ORG

Faculty of Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Faculty of Medicine About the Faculty of Medicine, University of Oslo With approximately one third of all medical students in Norway and almost two thirds of all PhD candidates, the Faculty of Medicine at the University of Oslo (UiO) has an important responsi- bility for providing high standards of medical education and research. The Faculty also offers a wide range of research and studies within health-related topics such as health administration, international health and nutrition. Norway has a well developed public health care system, and our researchers co-operate with different governmental bodies to ensure and support high standards. FACULTY OF MEDICINE Founded in 1814, the Faculty of Medicine is one of eight faculties at UiO. With approximately PO BOX 1078 Blindern, 0316 Oslo, Norway 1500 employees, our most important tasks are education, research and dissemination of Sogn Arena, 2. etg, Klaus Torgårds vei 3 information. The faculty’s annual budget is approximately 1 billion NOK (162 million USD), out Tel: +47 22 84 53 10 - Fax: +47 22 84 53 01 of which more than 50% are generated through external funding. UiO Faculty of Medicine F FACTS AND FIGURES (2009) OTO : THE University of Oslo (founded 1811) A n 7 000 employees TØ n Yearly budget: appr. 5.5 billion NOK (900 million USD) NN E S n 28 000 students E N , O S Oslo University Hospital L O n 20 000 employees UN n Yearly budget: appr. 18 billion NOK (3 billion USD) IVER S n I More than 1.2 million patients treated each year T E tssyk Akershus University Hospital n 5 000 employees EH n US Yearly budget: appr. 4 billion NOK (650 million USD) OG n About 450 000 patients treated each year Øyst EI N H . HO www.med.uio.no R GMO , UIO [email protected] F OTO : G UNNA R F. R F. Lot HE, UIO Design: Millimeterpress, Trykk: 07 Foto forside: Øystein H. Horgmo, UiO Approximately 3300 students (incl. PhD) attend our study programmes Medical School/MD Programme (one semester taught in English) Medical Student Research Programme (integrated in the MD Programme) PhD Programme (appr. 1200 registered candidates) Bachelor’s Degree Programmes: n Health Management and Health Economics n Nutrition Clinic, laboratory, society – translational research Master’s Degree Programmes: An international faculty n Health Economics, Policy and Management (in English) The research conducted at the faculty spans over a wide range of disciplines, from social sciences and n International Community Health (in English) Internationalisation is an integrated part of all activities at the Faculty of Medicine. This the humanities, basic medical sciences to clinical medicine and combinations of these. Researchers n Nutrition commitment is ensured through a growing international standardization of all educational with different backgrounds often work together in research and education, fostering a challenging and n Health Administration programmes. We have an active student exchange portfolio with a widespread network of rewarding inter- disciplinary environment. This has lead to exciting national and international projects n Health Sciences partner universities. The Faculty facilitates international cooperation with partners from the n like the Centres of ­Excellence, Centres of Research-based Innovation as well as other large and small Nursing Science European Research Area, North America, Russia, China, Argentina and South Africa in line n Suicidology, Addiction, Violence and Trauma – Psycho-social and Biological Intervention research co-operations. with its academic priorities. Likewise, the Faculty is proud of its engagement in research collaboration and transfer of competency with selected partners in Africa and South-East Asia. Samarbeidsorganet South-Eastern University of Oslo (Collaboration Norway Regional board) Health Authority Faculty of Medicine Faculty Administration Akershus University (incl. REK and RMI) Hospital F OTO : G Institute of Health Institute of Basic Institute of Clinical Oslo University UNNA and Society Medical Sciences Medicie Hospital R F. R F. Lot Close partnership with university hospitals HE, UIO F F OTO The Faculty consists of three institutes, in addition to the Institute for Forensic OTO : G : Øyst Medicine (RMI) and the Regional Committees for Research Ethics in Medicine and UNNA Health Care (REK). Research and education are based on a close partnership with EI the South-Eastern Norway Regional Health Authority and the two hospitals Akershus R F. N H University Hospital and Oslo University Hospital. About 50 % of the faculty’s academic Lot . HO staff are also employed at one of the university hospitals. This ensures a close HE, UIO R GMO connection between medical theory and clinical practice for students and researchers. The Faculty also collaborates with local hospitals and general , UIO practitioners in teaching medical students..
Load more

Recommended publications
  • Annual Report Research Activity 2019
    Annual Report Research Activity 2019 Division of Clinical Neuroscience University of Oslo and Oslo University Hospital 0 Contents Oslo University Hospital and the University of Oslo .................................................................................... 4 From Division Director Eva Bjørstad ........................................................................................................... 4 Division of Clinical Neuroscience (NVR) Organizational Chart ..................................................................... 5 Department of Physical Medicine and Rehabilitation Rehabilitation after trauma....................................................................................................................... 6 Group Leader: Nada Andelic Painful musculoskeletal disorders .............................................................................................................. 9 Group Leader: Cecilie Røe Department of Refractory Epilepsy - National Centre for Epilepsy Complex epilepsy .................................................................................................................................... 11 Group Leader: Morten Lossius Department of Neurosurgery Neurovascular-Hydrocephalus Research Group ..................................................................................... 16 Group Leader: Per Kristian Eide Oslo Neurosurgical Outcome Study Group (ONOSG) ................................................................................. 19 Group Leaders: Eirik Helseth and Torstein
    [Show full text]
  • Evaluation of Remdesivir and Hydroxychloroquine on Viral Clearance in Covid-19 Patients: Results from the NOR-Solidarity Randomised Trial
    Evaluation of remdesivir and hydroxychloroquine on viral clearance in Covid-19 patients: Results from the NOR-Solidarity Randomised Trial Andreas Barratt-Due1,2,9,*, Inge Christoffer Olsen3, Katerina Nezvalova Henriksen4,5, Trine Kåsine1,9, Fridtjof Lund-Johansen2,6, Hedda Hoel7,9,10, Aleksander Rygh Holten8,9, Anders Tveita11, Alexander Mathiessen12, Mette Haugli13, Ragnhild Eiken14, Anders Benjamin Kildal15, Åse Berg16, Asgeir Johannessen9,17, Lars Heggelund18,19, Tuva Børresdatter Dahl1,10, Karoline Hansen Skåra10, Pawel Mielnik20, Lan Ai Kieu Le21, Lars Thoresen22, Gernot Ernst23, Dag Arne Lihaug Hoff24, Hilde Skudal25, Bård Reiakvam Kittang26, Roy Bjørkholt Olsen27, Birgitte Tholin28, Carl Magnus Ystrøm29, Nina Vibeche Skei30, Trung Tran2, Susanne Dudman9,39, Jan Terje Andersen9,31, Raisa Hannula32, Olav Dalgard9,33, Ane-Kristine Finbråten7,34, Kristian Tonby9,35, Bjorn Blomberg36,37, Saad Aballi38, Cathrine Fladeby39, Anne Steffensen9, Fredrik Müller9,39, Anne Ma Dyrhol-Riise9,35, Marius Trøseid9,40 and Pål Aukrust9,10,40 on behalf of the NOR-Solidarity study group# 1Division of Critical Care and Emergencies, Oslo University Hospital, 0424 Oslo, Norway 2Division of laboratory Medicine, Dept. of Immunology, Oslo University Hospital, 0424 Oslo, Norway 3Department of Research Support for Clinical Trials, Oslo University Hospital, 0424 Oslo, Norway 4Department of Haematology, Oslo University Hospital, 0424 Oslo, Norway 5Hospital Pharmacies, South-Eastern Norway Enterprise, 0050 Oslo, Norway 6ImmunoLingo Covergence Centre, University
    [Show full text]
  • Project Estimation in the Norwegian Software Industry – a Summary
    Project Estimation in the Norwegian Software Industry – A Summary Kjetil Moløkken1, 2, Magne Jørgensen1, Sinan S. Tanilkan2, Hans Gallis1, Anette C. Lien1, Siw E. Hove1. March 3rd, 2004. 1 Simula Research Laboratory, P.O.Box 134, 1325 Lysaker, Norway. [kjetilmo, magnej, hansga, anetteli, siweh]@simula.no 2 Department of Informatics, P.O.Box 1080 Blindern, 0316 Oslo, Norway. [email protected] Simula Research Laboratory Martin Linges vei 15-25, Fornebu P.O. Box 134 NO-1325, Lysaker, Norway Telephone: +47 67 88 82 00 Telefax: +47 37 82 82 01 Executive Summary This report provides an overview of the results obtained from a survey on project estimation in Norwegian software companies. The survey was conducted between February and November 2003. The main results are: • We observed that 76% of the projects used more effort than estimated, while 19% used less. The average effort overrun was 41%. • Average effort overrun was 67% in projects with a public client, compared to an average effort overrun of 21% for projects with a private client. • Projects that used an incremental or evolutionary development approach had an average effort overrun of 24%, as opposed to the average 55% overrun for projects that used a waterfall-based development approach. The frequency and magnitude of effort overruns found in this survey seems to be similar to results reported from surveys conducted in other countries in the past 20 years. The observed differences in effort overruns between private and public projects may be caused by differences in bidding procedures, level of client involvement or acceptance procedures. In order to reduce the risk of effort overruns, software companies should: • Focus on analyzing their own estimation performance, and invest in estimation improvement (for instance through experience databases or work breakdown structures).
    [Show full text]
  • Motivation Letter Oslo, May 27Th, 2021 Dear ESGO Colleagues, I Am Writing
    Motivation letter Oslo, May 27th, 2021 Dear ESGO colleagues, I am writing to express my great interest in running for ESGO council. As an active member of the society for many years, I have enjoyed taking part in various meetings and educational activities both in-person and online, benefiting from the hard work and dedication of the ESGO leadership. To be a part of this leadership team would be very rewarding and a great honor. I currently have the privilege of holding the position of social media editor for the International Journal of Gynecological Cancer. In this role I have worked closely with editor in chief, Pedro Ramirez, and learned a great deal from him regarding academic leadership. I have initiated a virtual journal club, mentored editorial fellows and been able to grow the journals social media followers on Twitter from ca 100 to more than 3000 in two years. Through this experience I have also very much enjoyed collaborating with the ESGO office, and my fellow associate editors from ESGO. As a gynecologic oncologist at the Norwegian Radiumhospital my main focus is surgical treatment of gynecologic malignancies, both robotic surgery and radical cytoreductive procedures. Since my return from fellowship at MSKCC in 2015 I have taken on the lead of our Endometrial cancer and gyn sarcoma team, have been responsible for organizing the annual Tropé meeting on updates and controversies in gynecologic oncology with professor emeritus Claes Tropé, and more recently initiated a course in ovarian cancer surgery, this year in conjunction with ESGO. Thank you for the opportunity to apply for ESGO council.
    [Show full text]
  • The Language Youth a Sociolinguistic and Ethnographic Study of Contemporary Norwegian Nynorsk Language Activism (2015-16, 2018)
    The Language Youth A sociolinguistic and ethnographic study of contemporary Norwegian Nynorsk language activism (2015-16, 2018) A research dissertation submitteed in fulfillment of requirements for the degree of Master of Science by Research in Scandinavian Studies Track II 2018 James K. Puchowski, MA (Hons.) B0518842 Oilthigh Varsity o University of Dhùn Èideann Edinburgh Edinburgh Sgoil nan Schuil o School of Litreachasan, Leeteraturs, Literatures, Cànanan agus Leids an Languages and Culturan Culturs Cultures 1 This page intentionally left blank This page intentionally left blank 2 Declaration Declaration I confirm that this dissertation presented for the degree of Master of Science by Research in Scandinavian Studies (II) has been composed entirely by myself. Except where it is stated otherwise by reference or acknowledgement, it has been solely the result of my own fieldwork and research, and it has not been submitted for any other degree or professional qualification. For the purposes of examination, the set word-limit for this dissertation is 30 000. I confirm that the content given in Chapters 1 to 7 does not exceed this restriction. Appendices – which remain outwith the word-limit – are provided alongside the bibliography. As this work is my own, I accept full responsibility for errors or factual inaccuracies. James Konrad Puchowski 3 Abstract Abstract Nynorsk is one of two codified orthographies of the Norwegian language (along with Bokmål) used by around 15% of the Norwegian population. Originating out of a linguistic project by Ivar Aasen following Norway’s separation from Denmark and ratification of a Norwegian Constitution in 1814, the history of Nynorsk in civil society has been marked by its association with "language activist" organisations which have to-date been examined from historiographical perspectives (Bucken-Knapp 2003, Puzey 2011).
    [Show full text]
  • ERJ-03448-2020.Shareable
    ORIGINAL ARTICLE | INFECTION AND LUNG FUNCTION Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19 Tøri Vigeland Lerum1, Trond Mogens Aaløkken2,3, Eivind Brønstad4,5, Bernt Aarli6,7, Eirik Ikdahl8, Kristine Marie Aarberg Lund9, Michael T. Durheim3,10, Jezabel Rivero Rodriguez2, Carin Meltzer2, Kristian Tonby3,11, Knut Stavem 3,8,12, Ole Henning Skjønsberg1,3, Haseem Ashraf3,13,14 and Gunnar Einvik3,8,14 Affiliations: 1Dept of Pulmonary Medicine, Oslo University Hospital Ullevål, Oslo, Norway. 2Dept of Radiology and Nuclear Medicine, Oslo University Hospital Ullevål, Oslo, Norway. 3Institute for Clinical Medicine, University of Oslo, Oslo, Norway. 4Thoracic Dept, St Olavs Hospital, Trondheim, Norway. 5Dept of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences NTNU, Trondheim, Norway. 6Dept of Thoracic Medicine, Haukeland University Hospital, Haukeland, Norway. 7Dept of Clinical Science, University of Bergen, Bergen, Norway. 8Pulmonary Dept, Akershus University Hospital, Lørenskog, Norway. 9Dept of Infectious Diseases, Østfold Hospital Trust Kalnes, Grålum, Norway. 10Dept of Respiratory Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway. 11Dept of Infectious Diseases, Oslo University Hospital Ullevål, Oslo, Norway. 12Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway. 13Dept of Diagnostic Imaging, Akershus University Hospital, Lørenskog, Norway. 14Shared last authors. Correspondence: Gunnar Einvik, Pulmonary Dept, Akershus University Hospital, 1470 Lørenskog, Norway. E-mail [email protected] @ERSpublications 3 months after discharge, a quarter of COVID-19 survivors have reduced gas diffusion capacity and persistent parenchymal opacities. ICU treatment is associated with persistent parenchymal opacities, but not with dyspnoea or reduced diffusing capacity. https://bit.ly/2J3xH4x Cite this article as: Lerum TV, Aaløkken TM, Brønstad E, et al.
    [Show full text]
  • Source-Level EEG and Graph Theory Reveal Widespread Functional Network Alterations in Focal Epilepsy
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.17.20248426; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Title page Full title Source-level EEG and graph theory reveal widespread functional network alterations in focal epilepsy Authors and affiliations Christoffer Hatlestad-Hall1, Ricardo Bruña2,3,4, Marte Roa Syvertsen5, Aksel Erichsen1,6, Vebjørn Andersson1, Fabrizio Vecchio7, Francesca Miraglia7, Paolo M. Rossini7, Hanna Renvall8,9, Erik Taubøll1,10, Fernando Maestú2,3,4, and Ira H. Haraldsen1 1 Department of Neurology, Oslo University Hospital, Oslo, Norway 2 Center for Biomedical Technology, Technical University of Madrid, Pozuelo de Alarcón, Spain 3 Department of Experimental Psychology, Complutense University of Madrid, Pozuelo de Alarcón, Spain 4 Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain 5 Department of Neurology, Drammen Hospital, Vestre Viken Health Care Trust, Drammen, Norway 6 Department of Nuclear Medicine, Oslo University Hospital, Oslo, Norway 7 Brain Connectivity Laboratory, Department of Neuroscience and Neurorehabilitation, IRCCS San Raffaele Pisana, Rome, Italy 8 Department of Neuroscience and Biomedical Engineering, Aalto University, Helsinki, Finland 9 BioMag Laboratory, HUS Medical Imaging Center, Helsinki University Hospital, Helsinki, Finland 10 Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway Correspondence to: Christoffer Hatlestad-Hall Department of Neurology, Oslo University Hospital, PO Box 4956 Nydalen, 0424 Oslo, Norway Email: [email protected] NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
    [Show full text]
  • University of Oslo
    Now available at the Oslo Centre for Biostatistics and Epidemiology: A full time Researcher in biostatistics for clinical trials at Oslo University Hospital, possibly combined with a 20% Professor position at the University of Oslo. Oslo University Hospital (OUS), in partnership with the University of Oslo (UiO), is seeking outstanding, inspiring and enthusiastic candidates for a permanent position at the Oslo Centre for Biostatistics and Epidemiology (OCBE), Oslo, Norway. OCBE homepage: http://www.med.uio.no/imb/english/research/centres/ocbe/ We wish to recruit a biostatistician with strong competence in the methodology and practice of clinical trials, including complex designs and heterogeneous data. If the candidate is evaluated to have professor competence, then the position will be integrated with a 20% professor position at the Institute of Basic Medical Sciences, the Faculty of Medicine, UiO, Norway. This is an opportunity to join one of Europe's most active biostatistics groups at an exciting time. OCBE has staff affiliated with both OUS, in the department of Research Support Services, and UiO, in the Institute of Basic Medical Sciences. Currently, the centre includes seven tenured professors, four associate professors, fourteen researchers, and several post-doctoral fellows and PhD students, making up a group of about 55. OCBE is internationally recognized, with interests spanning a broad range of areas (including time-to-event models, data integration, causal inference, statistical genomics, Bayesian inference, Machine Learning, informative missingness and measurement error models, epidemiological studies of lifestyle and chronic diseases, stochastic models for infectious diseases, high dimensional data and models, clinical trials, register based studies) and numerous collaborations with a number of leading bio-medical research groups in Norway and internationally.
    [Show full text]
  • Professor Dr. Per Brandtzaeg
    December 2015 Professor Dr. Per Brandtzaeg Per BRANDTZAEG LIIPAT, Department of Pathology Oslo University Hospital, Rikshospitalet P.O. Box 4950 Nydalen 0424 Oslo, Norway Tel: 47-23 07 27 43 Fax: 47-23 07 15 11 E-mail: [email protected] Biographical Sketch Professor Per Brandtzaeg obtained his postgraduate training in microbiology, immunology and pathology at the Medical Center, Univ. of Alabama at Birmingham, AL, USA (1962-64) and received his PhD in immunology at the Univ. of Oslo (1971). He is the former Head of the Faculty Division, Rikshospitalet University Hospital, Oslo, and the founder (1965) of the Laboratory for Immunohistochemistry and Immunopathology (LIIPAT), Institute and Department of Pathology, which is devoted to research on mucosal immunity. He is also the founder (2001) of a thematic research network called the Center for Vaccinology and Immunotherapy (CEVI) at the University of Oslo, with a focus on basic mechanisms of importance for active and passive immunization. In 2007, CEVI obtained status as a Center of Excellence funded by the Research Council of Norway. Professor Brandtzaeg’s main research interest is in the immunobiology and immunopathology of mucous membranes. He obtained the top score of leading European scientists in the field of mucosal immunology in a worldwide peer judgement carried out by the US National Academy of Sciences Immunology Benchmarking Panel in 1998, and has been one of Norway’s most cited researchers over the last two decades. He has received several major national and international science awards, and is Commander of the Royal Norwegian Order of St. Olav. Brief Curriculum Vitae Personal data Born 9 June 1936 in Bergen, Norway.
    [Show full text]
  • KOMPLEKS 99335701 Blindern
    KOMPLEKS 99335701 Blindern Bygnings- og eiendomsdata Fylke: Oslo Kommune: 301/Oslo kommune Opprinnelig funksjon: Universitet Nåværende funksjon: Universitet Foreslått vernekategori: Verneklasse 1, fredning Totalt antall bygg: 36 Universitetsplassen sett fra sør. Opphavsrett: UiO. Situasjonskart. Opphavsrett: Statsbygg. Side 1 KOMPLEKS 99335701 Blindern Bygningsoversikt, omfang vern Byggnr Byggnavn Oppført Verneklasse Omfang GAB nr Gnr/Bnr 10166 BL01 ADMINISTRASJONSBYGNINGEN 1959 - 1964 Verneklasse 1, fredning Eksteriør 081208972 38/1 11376 BL02 LAVBLOKKA 1960 - 1963 Verneklasse 1, fredning Eksteriør 081208972 38/1 10164 BL03 FREDERIKKE 1959 - 1961 Verneklasse 1, fredning Eksteriør 080762259 38/1 10165 BL04 IDRETTSBYGNINGEN 1959 - 1962 Verneklasse 2, bevaring Eksteriør 080762259 38/1 10160 BL05 SOPHUS BUGGES HUS 1960 - 1962 Verneklasse 2, bevaring Eksteriør/Interiør 081215944 38/1 10162 BL06 HENRIK WERGELANDS HUS 1960 - 1962 Verneklasse 2, bevaring Eksteriør/Interiør 081142068 38/1 10163 BL07 P A MUNCHS HUS 1962 Verneklasse 2, bevaring Eksteriør/Interiør 081142068 38/1 10161 BL08 NIELS TRESCHOWS HUS 1960 - 1963 Verneklasse 2, bevaring Eksteriør/Interiør 081142068 38/1 10170 BL09 EILERT SUNDTS HUS A 1965 - 1967 Verneklasse 1, fredning Eksteriør/Interiør 080762267 44/85 14337 BL10 Eilert Sundts hus, blokk B 1965 - 1967 Verneklasse 1, fredning Eksteriør/Interiør 081571120 44/85 14338 BL11 Harriet Holters hus 1965 - 1967 Verneklasse 1, fredning Eksteriør 081571139 44/85 11377 BL13 VILHELM BJERKNES HUS 1965 - 1966 Verneklasse 1, fredning Eksteriør/Interiør
    [Show full text]
  • ANNUAL REPORT 2018 3 Introduction by the Director
    Oslo University Hospital The Norwegian Radium Hospital INSTITUTE Institute for Cancer Research FORINSTITUTE CANCER Ullernchausseen 70 RESEARCH N–0379 Oslo FOR CANCER Norway P.O. BOX 4953 Nydalen RESEARCH N–0424 Oslo Norway ANNUAL http://ous-research.no/institute/ REPORTAnnual 201Report7 INSTITUTE FOR CANCER RESEARCH CANCER FOR INSTITUTE 2018 ANNUAL REPORT 2017 REPORT ANNUAL Contents 4 Introduction by the Director 6 The Institute for Cancer Research into the future 8 Organisation and key figures 12 Oslo University Hospital Comprehensive Cancer Centre 14 Departments and research groups 16 Cancer Genetics 22 Cancer Immunology EDITORIAL STAFF: 30 Molecular Cell Biology Kjetil Taskén Gunhild M. Mælandsmo 36 Molecular Oncology Peter Wiedswang Kari Aalrust Berger 42 Radiation Biology 48 Tumor Biology DESIGN: Espen Liland 54 Core Facilities PHOTOGRAPHY: Terje Heiestad The photographic theme of this year’s Annual Report is Humans at ICR. - The most important part of ICR is 58 Research centres by far its human resources and our collective competence. 60 Centre of Excellence 62 K. G. Jebsen Centres FRONT PAGE: Light, protons and neutrons are utilised 68 Norwegian Cancer Genomics Consortium to activate photosensitizers for cancer therapy. This is funded by two new EU Horizon2020 Future Emerging Technologies (FET-OPEN) grants to 70 International Collaboration Department of Radiation Biology (Theo Theodossiou and Kristian Berg) along 72 Recent Innovations with support from HSØ. Here: Diode 74 Publications laser-based PCI treatment. PAPER: 150/300 Profimatt CIRCULATION: 800 INSTITUTE FOR CANCER RESEARCH | ANNUAL REPORT 2018 3 Introduction by the Director The Institute for Cancer Research (ICR) is an Society to Vessela Kristensen, the award of the UiO institution with approximately 350 employees Research Prize to Harald Stenmark, the Ragnar Mørk’s plus students organised in 24 research groups Prize for Outstanding Research to Kaisa Haglund and complemented with cutting-edge core facilities.
    [Show full text]
  • Supplementary Material Evidence for Widespread Alterations in Cortical
    Supplementary Material Evidence for widespread alterations in cortical microstructure after 32 hours of sleep deprivation Authors: Irene Voldsbekka,b,c,*, Atle Bjørnerud a,c,d, Inge Grootec, Nathalia Zak b,f, Daniel Roelfs b,g, Ivan I. Maximov a,b,h, Oliver Geier f, Paulina Due-Tønnesseni, Erlend Bøenj, Yvonne S. Kuiperf, Lise-Linn Løkkenf, Marie Strømstada, Taran Y. Blakstvedta, Bjørn Bjorvatnk,l, Ulrik F. Maltg, Lars T. Westlyea,b,m, Torbjørn Elvsåshagen b,g,n, Håkon Grydelanda,o,* a Department of Psychology, University of Oslo, Oslo, Norway. b Norwegian Centre for Mental Disorders Research (NORMENT), Oslo University Hospital, Oslo, Norway. c Computational Radiology and Artificial Intelligence (CRAI), Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway. d Department of Physics, University of Oslo, Oslo, Norway. e Department of Radiology, Vestfold Hospital Trust, Tønsberg, Norway. f Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway. g Institute of Clinical Medicine, University of Oslo, Oslo, Norway. h Department of Health and Functioning, Western Norway University of Applied Sciences, Bergen, Norway. i Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway. j Psychosomatic and CL Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. k Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. l Norwegian Competence Center for Sleep Disorders, Haukeland University Hospital, Bergen, Norway. m KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway. n Department of Neurology, Oslo University Hospital, Oslo, Norway. o Center for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Norway.
    [Show full text]